secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001654954-23-014163
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica Q3 revenue up 31% to record $6.3M; net loss narrows to $0.3M; NYSE listing deficiency
--------------------------------------------------------------------------------

- Revenue of $6.3M, up 31% YoY; gross margin 69%, up from 67% sequential.
- Net loss narrowed to $0.3M ($0.001/share) from $5.8M ($0.005/share) a year ago.
- Non-GAAP EBITDA loss $0.3M vs $3.0M loss; adjusted non-GAAP EBITDA profit $0.3M.
- Liquidity $118M; completed acquisitions of SMP (VetGuardian) and Qorvo Biotechnologies.
- NYSE American notified of low share price deficiency; 30-day avg <$0.20; company plans cure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495423014163/0001654954-23-014163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495423014163/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-014163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer